Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC. Stock Analysis 4017.SR

Dr. Soliman Abdel Kader Fakeeh Hospital Co. engages in the managing, establishing, and operating hospitals, clinics, medical, educational, and training centers. The company is headquartered in Jeddah, Makkah. The company went IPO on 2024-06-05. The company offers its medical services through six units: Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.